The multiple inert gas elimination technique (MIGET) was first described by Wagner et al in 1974.' It allows quantitation of the ventilationperfusion (VA/Q) distribution and a precise analysis of the intrapulmonary and extrapulmonary factors that govern gas exchange in humans. This review discusses how this technique has facilitated a better understanding of the mechanisms underlying gas exchange in two common chronic lung diseases -chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis. The methodological aspects ofthe MIGET are not discussed, and the interested reader is referred to the first review in this series (Thorax 1994;49:815-824) or to some comprehensive reviews published recently on this subject.2
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Chronic obstructive pulmonary disease (COPD) Gas exchange abnormalities in COPD range from mild hypoxaemia to severe respiratory failure requiring mechanical ventilation. It was widely assumed that VA/Q mismatching probably was the major mechanism underlying such abnormalities. However, the MIGET has contributed to clarifying the following, previously unresolved, questions: (1) what are the basic mechanisms of abnormal gas exchange in COPD (VA/Q mismatch versus shunt versus oxygen diffusion limitation)? (2) what are the correlations (if any) between such mechanisms and lung structure? (3) what are the effects of exercise upon VA/Q mismatch in COPD? (4) how does oxygen breathing interact with the VA/Q distributions of these patients? (5) how do bronchodilators modify the baseline VA/Q distribution? and, finally (6) what are the effects of vasodilators upon VA/Q inequality?
MECHANISMS OF ABNORMAL GAS EXCHANGE
The MIGET has shown in COPD that, as anticipated, these patients have severe degrees of VA/Q mismatching. Interestingly, this mechanism of abnormal gas exchange accounts completely for the observed degree of arterial hypoxaemia.3 Conversely, it has been shown that true shunt and oxygen diffusion limitation do not generally play a significant part in the genesis of arterial hypoxaemia in these subjects. The type and severity of VA/Q mismatch has been found to differ among patients with COPD and to change with time, according to the evolution of the disease and the clinical state of the patient.
In a group of patients with severe COPD Wagner and coworkers3 described two different patterns of VA/Q mismatch. In some patients VA/Q inequality was mainly characterised by the presence of lung units with a very high VA/Q ratio ("high pattern") ( fig 1) . By contrast, other patients exhibited a pattern of VA/Q distribution characterised by the presence of lung units with very low VA/Q ratios ("low pattern") ( fig 1) . While the "high pattern" was more prevalent in patients fulfilling the criteria of the "emphysematous type" of COPD, according to the classification proposed by Burrows MIGET allows a precise dissection of the role of such factors in these patients. Patients with moderate COPD may not develop pulmonary hypertension at rest; however, most of them will demonstrate it during exercise. We assessed the effects of nifedipine on VA/Q distributions and pulmonary haemodynamics during exercise in a group of patients with COPD and mild pulmonary hypertension at rest.5 Nifedipine reduced the increase in pulmonary vascular resistance observed during exercise without the drug but also significantly worsened VA/Q matching. These data suggest that the deleterious effect of vasodilators on VA/Q relations is also apparent during exercise and that hypoxic pulmonary vasoconstriction is an important mechanism in enhancing VA/Q matching also while exercising.5
Idiopathic pulmonary fibrosis Patients with idiopathic pulmonary fibrosis (IPF) characteristically present with dyspnoea on exertion, loss of lung volume, reduced transfer factor for carbon monoxide (TLCO), and mild arterial hypoxaemia at rest that worsens during exercise. 23 The latter had been considered almost a hallmark of the disease. Despite this well known clinical picture, before the MIGET became available several questions remained poorly understood. Most prominent among them were: (1) what is the precise mechanism of abnormal gas exchange in lung fibrosis -that is, VA/Q inequality or oxygen diffusion limitation -particularly during exercise? (2) how does the pulmonary vasculature interact with the mechanisms of abnormal pulmonary gas exchange? and (3) Figure   5 presents the VA/Q distribution obtained in two of those patients. At rest, breathing room air, both patients showed relatively well preserved VA/Q distributions with a very small amount of shunt and/or blood flow perfusing units with low VA/Q ratios. The observation of minimal abnormalities in the VA/Q distribution of these patients is consistent with the fact that they usually have minimal hypoxaemia at rest. 23 The MIGET can predict the arterial Po2 value that should result from the measured VA/Q distribution, taking into account all the factors that may influence gas exchange in humans (FiO2, minute ventilation, cardiac output), on the explicit assumption that there is no oxygen diffusion limitation' ". The comparison of this predicted Po2 value with that actually measured in the arterial blood thus provides information on any hypothetical "alveolar-capillary block for oxygen". Figure 6 shows that, in patients with IPF, both at rest and (more) during exercise, the predicted Po2 value was systematically higher than the measured Pao2. 3 Ventilation-perfusion ratio Figure 5 Ventilation-perfusion distribution obtained in two representative patients with idiopathic pulmonary fibrosis studied at rest breathing room air, at rest breathing 100% oxygen, and during exercise (breathing room air It can therefore be concluded that: (1) when analysing pulmonary gas exchange in patients with interstitial lung disease it is important not to mix patients with different interstitial diseases into a single group; (2) in IPF (and also in sarcoidosis) the basic mechanism of arterial hypoxaemia at rest is VA/Q inequality, but some oxygen diffusion limitation is also apparent (even at rest). During exercise both mechanisms share similar pathophysiological relevance; and (3) during exercise the increase in oxygen diffusion limitation is probably due both to the shorter capillary transit time and to the lower mixed venous P02.
INTERACTIONS OF PULMONARY VASCULAR DAMAGE AND GAS EXCHANGE
In advanced stages of the disease, patients with IPF develop pulmonary hypertension,23 classically explained by the reduced capillary surface IOgSD Q 100% 02 (% baseline) Figure 7 On the abscissa, change in the dispersion of the perfusion distribution while breathing 100% oxygen (% change from baseline conditions) (AlogsD Q (fig 5) . 30 The increase in perfusion ofpoorly ventilated lung units while breathing pure oxygen represents release of hypoxic pulmonary vasoconstriction.253034 Such an increase can be calculated using the MIGET as the percentage change from baseline in the dispersion of the perfusion distribution while breathing 100% oxygen (AlOgSD Q).30 This variable may be more sensitive to small changes of the pulmonary vascular tone than the standard pressure-flow measurements.25'3034 Figure 7 shows AlogsD Q plotted against (A) the exercise values of mean pulmonary artery pressure, (B) DISP R-E* (an overall index of VA/Q mismatch), and (C) arterial Po2 measured in patients with IPF. It is of the greatest interest to observe that the higher the pulmonary vascular response to oxygen at rest (higher AlogsD Q), the less is the severity of the pulmonary hypertension developed during exercise (panel A); also, those patients with more vascular reactivity at rest associate less VA/Q mismatch (panel B) and a higher arterial Po2 (panel C) during exercise.
In summary, these data indicate that those patients with IPF and with fixed changes of the pulmonary vasculature (probably because they also have a more advanced clinical disease) did not show any (or minimal) evidence of hypoxic vasoconstriction being released by oxygen at rest and, at the same time, these patients were those who showed more severe pulmonary hypertension, more VA/Q mismatch, and lower arterial Po2 during exercise (fig 7) . RELATION hypertension.' Figure 8 shows that Kco (that is, TLCO normalised for the measured alveolar volume) expressed as a percentage of the reference value was significantly related to the overall degree of pulmonary gas exchange impairment during exercise (expressed as the alveolar-arterial oxygen gradient, panel A) and also to the two basic mechanisms of gas exchange impairment during exercise in IPF (see above): a limitation in the diffusion of oxygen (panel B) and the degree of VA/Q inequality (panel C). It was also observed (graph not shown) that the lower the Kco (% reference) the greater the increase in pulmonary vascular resistance during exercise which, as an index of pulmonary vascular compliance, is an estimate of the surface available for capillary perfusion. The degree of statistical significance of all these correlations was considerably lower when tLCO was considered.
"
Taken all together, these data indicate that the measurement of the diffusing capacity of carbon monoxide in IPF is an indicator of (1) the overall degree of gas exchange impairment to be expected during exercise and, as a corollary, of the two basic mechanisms of exertional hypoxaemia in these patients (VA/Q mismatch and oxygen diffusion limitation); and (2) the amount of pulmonary vascular derangement present and, possibly, also of the degree of vascular reactivity. From the clinical standpoint, and given that the statistical strength of the observed relations was much higher for Kco than for TLCO, we would recommend the use of the former in the clinical evaluation of these patients. 
